Log in

Ionic liquids as biocompatible stabilizers of proteins

  • Review
  • Published:
Biophysical Reviews Aims and scope Submit manuscript

Abstract

Ionic liquids (ILs) have recently emerged as versatile solvents and additives in the field of biotechnology, particularly as stabilizers of proteins and enzymes. Of interest to the biotechnology industry is the formulation of stable biopharmaceuticals, therapeutic proteins, and vaccines which have revolutionized the treatment of many diseases including debilitating conditions such as cancers and auto-immune diseases. The stabilization of therapeutic proteins is typically achieved using additives that prevent unfolding and aggregation of these proteins during manufacture, transport, and long-term storage. To determine if ILs could be used in the formulation of stable therapeutic proteins, a thorough understanding of the effects of ILs on protein stability is needed, as well as understanding the toxicity of ILs on humans, and other considerations for formulation development such as viscosity and osmolality. In this review, we summarize recent developments on the stabilization of proteins and enzymes using ILs, with emphasis on identifying biocompatible ILs that may be suitable for the formulation of stable biopharmaceuticals in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ILs:

Ionic liquids

PIL:

Protic ionic liquid

AIL:

Aprotic ionic liquid

EAN:

Ethylammonium nitrate

DHP:

Dihydrogen phosphate

Chol:

Choline

BMIM:

1-Butyl-3-methyilimidazolium

EMIM:

1-Ethyl-3-methylimidazolium

PMIM:

1-Methyl-3-propylimidazolium

HMIM:

1-Hexyl-3-methylimidazolium

MMIM:

1,3-Dimethylimidazolium

SCN:

Thiocyanate

Cyt C:

Cytochrome complex

BSA:

Bovine serum albumin

rPa:

Recombinant plasminogen activator

MDEG:

2(2-Methoxyethoxy)-ethyl

HexSO4 :

Hexylsulfate

Tos:

Tosylate

OH-EMIM:

1-(2-Hydroxyethyl)-3-methylimidazolium

OH-PMIM:

1-(3-Hydroxypropyl)-3-methylimidazolium

OH-HMIM:

1-(6-Hydroxyhexyl)-3-methylimidazolium

BF4 :

Tetrafluoroborate

CT:

α-Chymotrypsinogen

BzMIM:

1-Benzyl-3-methylimidazolium

TEAA:

Triethylammonium acetate

TEAP:

Triethylammonium phosphate

TBPBr:

Tetrabutylphosphonium bromide

Ac:

Acetate

Cit:

Citrate

rHIL-2:

Recombinant human interleukin-2

TMA:

Trimethyl acetate

Lac:

Lactate

Prop:

Propionate

Hex:

Hexanoate

DMP:

Dimethyl phosphate

TFMS:

Trifluoromethane sulfonate

TF2N:

Bis(trifluoromethylsulfonyl)amide

Glu:

Glutarate

GuHCl:

Guanidine hydrochloride

mAb:

Monoclonal antibody

EGFR:

Epidermal growth factor receptor

MD:

Molecular dynamics

DBP:

Dibutyl phosphate

BEH:

Bis(2-ethylhexyl) phosphate

TMP:

Bis(2,4,4-trimethylpentyl) phosphinate

DEP:

O,O′-diethyl dithiophosphate

EOOEMIM:

3-Methyl-1-(ethoxycarbonylmethyl)imidazolium

[EOOEMPy][C12SO4]:

3-Methyl-1-(ethoxycarbonylmethyl)pyrrolidinium

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Veysel Kayser.

Ethics declarations

Conflict of interest

Mouhamad Reslan declares that he has no conflict of interest. Veysel Kayser declares that he has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

This article is part of a Special Issue on ‘Ionic Liquids and Biomolecules’ edited by Antonio Benedetto and Hans-Joachim Galla.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reslan, M., Kayser, V. Ionic liquids as biocompatible stabilizers of proteins. Biophys Rev 10, 781–793 (2018). https://doi.org/10.1007/s12551-018-0407-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12551-018-0407-6

Keywords

Navigation